Tumour driver mutations compromise between cancer growth and immune responses

  • RESEARCH BRIEFINGS

Numerous theories have tried to clarify the frequency and consistency of ‘hotspot’ mutations in lots of tumour-driving genes throughout totally different cancers. A mannequin of the health profit of those mutations exhibits that elementary trade-offs happen between a tumour’s progress and its visibility to the immune system, with potential therapeutic implications.

Source link

Comments

0 comments

Leave a comment

Your email address will not be published. Required fields are marked *